10222 BARNES CANYON ROAD, BLDG. #2, SAN DIEGO, CA
Jeff Knight Resigns as Chief Development and Operating Officer
Crinetics Pharmaceuticals Dismisses BDO as Independent Auditor
Financial Results, Press Release
Executive Title Change - Jeff Knight Promoted to Chief Development Officer
Beyond Building Innovation the Premier to Impact: Endocrinology Business Conference
Announces Pricing of Public Offering of Common Stock
Crinetics Reports Positive Phase 2 Results for Atumelnant in CAH
Dr. Dana Pizzuti Steps Down as Chief Medical Officer at Crinetics
FY 2024
Q3
Q2
Q1
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership